Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes

Genes Chromosomes and Cancer

Volumn 51, Issue 12, 2012, Pages 1154-1164

  Celestino, Ricardo ^a,b,c,d   Sigstad, Eva ^a   Løvf, Marthe ^a,c   Thomassen, Gard O S ^a,c   Grøholt, Krystyna K ^a   Jørgensen, Lars H ^a   Berner, Aasmund ^a,c   Castro, Patrícia ^b,d   Lothe, Ragnhild A ^a,c   Bjøro, Trine ^a,c   Sobrinho Simões, Manuel ^b,d,e   Soares, Paula ^b,d   Skotheim, Rolf I ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF OSLO   (Norway)

^d University of Porto   (Portugal)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR THYROID ADENOMA; FUSION GENE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; ONCOGENE; PAX8 PPARG FUSION GENE; PRIORITY JOURNAL; RET PTC1 FUSION GENE; RET PTC3 FUSION GENE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMORIGENESIS;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA; CHROMOSOME ABERRATIONS; FEMALE; GENE FUSION; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; THYROID GLAND; THYROID NEOPLASMS;

ALIAS;

EID: 84867233863     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22003     Document Type: Article

References (32)

1. Castro P, Rebocho AP, Soares RJ, Magalhaes J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simoes M. 2006. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91: 213-220.
2. De Vries MM, Celestino R, Castro P, Eloy C, Maximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simoes M, Soares P. 2012. RET/PTC rearrangement is prevalent in follicular Hurthle cell carcinomas. Histopathology. http://www.ncbi.nlm.nih.gov/pubmed/22803838.
3. DeLellis RA, Lloyd RV, Heitz PU, Eng C. 2004. WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press.
4. Di Cristofaro J, Marcy M, Vasko V, Sebag F, Fakhry N, Wynford-Thomas D, De Micco C. 2006. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant. Hum Pathol 37: 824-830.
5. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004. A census of human cancer genes. Nat Rev Cancer 4: 177-183.
6. Kondo T, Ezzat S, Asa SL. 2006. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306.
7. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA. 2000. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289: 1357-1360.
8. Lima J, Trovisco V, Soares P, Maximo V, Magalhaes J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simoes M. 2004. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4267-4271.
9. Løvf M, Thomassen GO, Bakken AC, Celestino R, Fioretos T, Lind GE, Lothe RA, Skotheim RI. 2011. Fusion gene microarray reveals cancer type-specificity among fusion genes. Genes Chromosomes Cancer 50: 348-357.
10. Lu Q, Nunez E, Lin C, Christensen K, Downs T, Carson DA, Wang-Rodriguez J, Liu YT. 2008. A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants. Nucleic Acids Res 36: e130.
11. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V. 2002. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947-3952.
12. Marques AR, Espadinha C, Frias MJ, Roque L, Catarino AL, Sobrinho LG, Leite V. 2004. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. Br J Cancer 91: 732-738.
13. Mitelman F, Johansson B, Mertens F. 2009. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed: 2009.
14. Nakazawa T, Murata S, Kondo T, Niu D, Mochizuki K, Kawasaki T, Yamane T, Nakamura N, Katoh R. 2009. RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation. Virchows Arch 455: 35-41.
15. Nasedkina T, Domer P, Zharinov V, Hoberg J, Lysov Y, Mirzabekov A. 2002. Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays. Haematologica 87: 363-372.
16. Nasedkina TV, Zharinov VS, Isaeva EA, Mityaeva ON, Yurasov RN, Surzhikov SA, Turigin AY, Rubina AY, Karachunskii AI, Gartenhaus RB, Mirzabekov AD. 2003. Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach. Clin Cancer Res 9: 5620-5629.
17. Nikiforov YE. 2002. RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13: 3-16.
18. Novo FJ, de Mendibil IO, Vizmanos JL. 2007. TICdb: a collection of gene-mapped translocation breakpoints in cancer. BMC Genomics 8: 33.
19. Panagopoulos I, Aman P, Fioretos T, Hoglund M, Johansson B, Mandahl N, Heim S, Behrendtz M, Mitelman F. 1994. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11: 256-262.
20. Placzkowski KA, Reddi HV, Grebe SK, Eberhardt NL, McIver B. 2008. The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer. PPAR Res 2008: 672829.
21. Shi RZ, Morrissey JM, Rowley JD. 2003. Screening and quantification of multiple chromosome translocations in human leukemia. Clin Chem 49: 1066-1073.
22. Skotheim RI, Thomassen GO, Eken M, Lind GE, Micci F, Ribeiro FR, Cerveira N, Teixeira MR, Heim S, Rognes T, Lothe RA. 2009. A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Mol Cancer 8: 5.
23. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M. 1998. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol 185: 71-78.
24. Sobrinho-Simoes M, Maximo V, Rocha AS, Trovisco V, Castro P, Preto A, Lima J, Soares P. 2008. Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am 37: 333-362, viii.
25. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. 1994. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6: 146-151.
26. Tallini G, Asa SL. 2001. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 8: 345-354.
27. Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A. 1998. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4: 287-294.
28. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G. 1999. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84: 4232-4238.
29. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
30. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G. 2004. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 89: 4272-4279.
31. Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE. 2006. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab 91: 3603-3610.
32. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE. 2003. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120: 71-77.